Premature termination codons in theDMDgene cause reduced local mRNA synthesis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Premature termination codons in theDMDgene cause reduced local mRNA synthesis
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 117, Issue 28, Pages 16456-16464
Publisher
Proceedings of the National Academy of Sciences
Online
2020-07-03
DOI
10.1073/pnas.1910456117
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A multicenter comparison of quantification methods for antisense oligonucleotide-induced DMD exon 51 skipping in Duchenne muscular dystrophy cell cultures
- (2018) Monika Hiller et al. PLoS One
- The RNA Surveillance Factor UPF1 Represses Myogenesis via Its E3 Ubiquitin Ligase Activity
- (2017) Qing Feng et al. MOLECULAR CELL
- Eteplirsen in the treatment of Duchenne muscular dystrophy
- (2017) Kenji Rowel Lim et al. Drug Design Development and Therapy
- Eteplirsen: First Global Approval
- (2016) Yahiya Y. Syed DRUGS
- Histological effects of givinostat in boys with Duchenne muscular dystrophy
- (2016) Paolo Bettica et al. NEUROMUSCULAR DISORDERS
- Mechanism and regulation of the nonsense-mediated decay pathway
- (2016) Nele Hug et al. NUCLEIC ACIDS RESEARCH
- Functional correction in mouse models of muscular dystrophy using exon-skipping tricyclo-DNA oligomers
- (2015) Aurélie Goyenvalle et al. NATURE MEDICINE
- European Medicines Agency review of ataluren for the treatment of ambulant patients aged 5 years and older with Duchenne muscular dystrophy resulting from a nonsense mutation in the dystrophin gene
- (2015) Manuel Haas et al. NEUROMUSCULAR DISORDERS
- Non-sequential and multi-step splicing of the dystrophin transcript
- (2015) Isabella Gazzoli et al. RNA Biology
- A feedback loop between nonsense-mediated decay and the retrogene DUX4 in facioscapulohumeral muscular dystrophy
- (2015) Qing Feng et al. eLife
- Coordinated Histone H3 Methylation and Acetylation Regulate Physiologic and Pathologic Fas Ligand Gene Expression in Human CD4+ T Cells
- (2014) S. S. Ghare et al. JOURNAL OF IMMUNOLOGY
- Low dystrophin levels in heart can delay heart failure in mdx mice
- (2014) Maaike van Putten et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy
- (2014) Jean K. Mah et al. NEUROMUSCULAR DISORDERS
- DMD transcript imbalance determines dystrophin levels
- (2013) Pietro Spitali et al. FASEB JOURNAL
- Clinical characterisation of Becker muscular dystrophy patients predicts favourable outcome in exon-skipping therapy
- (2013) J. C. van den Bergen et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Muscular dystrophies
- (2013) Eugenio Mercuri et al. LANCET
- Use of Bru-Seq and BruChase-Seq for genome-wide assessment of the synthesis and stability of RNA
- (2013) Michelle T. Paulsen et al. METHODS
- Phase 2a Study of Ataluren-Mediated Dystrophin Production in Patients with Nonsense Mutation Duchenne Muscular Dystrophy
- (2013) Richard S. Finkel et al. PLoS One
- Development of Multiexon Skipping Antisense Oligonucleotide Therapy for Duchenne Muscular Dystrophy
- (2013) Yoshitsugu Aoki et al. Biomed Research International
- Biochemical Characterization of Patients With In-Frame or Out-of-FrameDMDDeletions Pertinent to Exon 44 or 45 Skipping
- (2013) Karen Anthony et al. JAMA Neurology
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- Correlation analysis of clinical parameters with epigenetic modifications in the DUX4 promoter in FSHD
- (2012) Judit Balog et al. Epigenetics
- The DMD Locus Harbours Multiple Long Non-Coding RNAs Which Orchestrate and Control Transcription of Muscle Dystrophin mRNA Isoforms
- (2012) Matteo Bovolenta et al. PLoS One
- Pip6-PMO, A New Generation of Peptide-oligonucleotide Conjugates With Improved Cardiac Exon Skipping Activity for DMD Treatment
- (2012) Corinne Betts et al. Molecular Therapy-Nucleic Acids
- Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
- (2011) Sebahattin Cirak et al. LANCET
- Systemic Administration of PRO051 in Duchenne's Muscular Dystrophy
- (2011) Nathalie M. Goemans et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nonsense mutation-associated Becker muscular dystrophy: interplay between exon definition and splicing regulatory elements within the DMD gene
- (2010) Kevin M. Flanigan et al. HUMAN MUTATION
- Read-Through Strategies for Suppression of Nonsense Mutations in Duchenne/ Becker Muscular Dystrophy: Aminoglycosides and Ataluren (PTC124)
- (2010) Richard S. Finkel JOURNAL OF CHILD NEUROLOGY
- Preclinical PK and PD Studies on 2′-O-Methyl-phosphorothioate RNA Antisense Oligonucleotides in the mdx Mouse Model
- (2010) Hans Heemskerk et al. MOLECULAR THERAPY
- Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data
- (2009) J. M. Ruijter et al. NUCLEIC ACIDS RESEARCH
- Network Analysis of Differential Expression for the Identification of Disease-Causing Genes
- (2009) Daniela Nitsch et al. PLoS One
- Transcriptional behavior of DMD gene duplications in DMD/BMD males
- (2008) F. Gualandi et al. HUMAN MUTATION
- Expression of the muscle glycogen phosphorylase gene in patients with McArdle disease: the role of nonsense-mediated mRNA decay
- (2007) Gisela Nogales-Gadea et al. HUMAN MUTATION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now